We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
+9.78%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$258B
AUM Growth
+$11.2B
(+4.5%)
Cap. Flow
-$8.74B
Cap. Flow
% of AUM
-3.39%
Top 10 Holdings %
Top 10 Hldgs %
19.2%
Holding
3,329
New
40
Increased
1,011
Reduced
1,986
Closed
159
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Prologis
PLD
|
+$352M |
| 2 |
Merck
MRK
|
+$333M |
| 3 |
NVIDIA
NVDA
|
+$306M |
| 4 |
Atlassian
TEAM
|
+$280M |
| 5 |
Corteva
CTVA
|
+$253M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alnylam Pharmaceuticals
ALNY
|
+$3.41B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$331M |
| 3 |
iShares Russell 1000 Growth ETF
IWF
|
+$266M |
| 4 |
Danaher
DHR
|
+$240M |
| 5 |
TWTR
Twitter, Inc.
TWTR
|
+$237M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.56% |
| 2 | Healthcare | 14.16% |
| 3 | Financials | 12.95% |
| 4 | Consumer Discretionary | 9.76% |
| 5 | Industrials | 9.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1051
Materion
MTRN
$6.04B
| $19.1M | 0.01% |
218,169
-147,098
| -40% | -$12M |
|
1052
FirstCash
FCFS
$8.78B
| $19.1M | 0.01% |
219,482
+36,299
| +20% | +$3.21M |
|
1053
Toast
TOST
$19.9B
| $19.1M | 0.01% |
1,057,455
+51,236
| +5% | +$963K |
|
1054
Schneider National
SNDR
$6.25B
| $19.1M | 0.01% |
814,063
-23,076
| -3% | -$540K |
|
1055
Artisan Partners
APAM
$3.02B
| $19M | 0.01% |
641,118
+236,957
| +59% | +$7.28M |
|
1056
CACI
CACI
$14.2B
| $19M | 0.01% |
63,348
-6,791
| -10% | -$1.98M |
|
1057
Harley-Davidson
HOG
$2.71B
| $19M | 0.01% |
457,059
-42,684
| -9% | -$1.82M |
|
1058
AMN Healthcare
AMN
$1.4B
| $19M | 0.01% |
184,562
-28,713
| -13% | -$3.31M |
|
1059
Ryder
R
$10.1B
| $19M | 0.01% |
226,956
-11,507
| -5% | -$966K |
|
1060
Mercury Systems
MRCY
$6.52B
| $18.9M | 0.01% |
423,555
-22,074
| -5% | -$1.04M |
|
1061
Organon & Co
OGN
$3.57B
| $18.9M | 0.01% |
678,199
-28,794
| -4% | -$736K |
|
1062
Dave & Buster's
PLAY
$357M
| $18.9M | 0.01% |
533,187
-35,471
| -6% | -$1.28M |
|
1063
Antero Midstream
AM
$10.1B
| $18.9M | 0.01% |
1,750,277
+122,288
| +8% | +$1.3M |
|
1064
Varonis Systems
VRNS
$5B
| $18.8M | 0.01% |
786,250
-301,507
| -28% | -$6.89M |
|
|
NEWR
1065
DELISTED
New Relic, Inc.
NEWR
| $18.8M | 0.01% |
333,404
-40,435
| -11% | -$2.29M |
|
1066
Kforce
KFRC
$1.06B
| $18.8M | 0.01% |
342,622
-28,473
| -8% | -$1.64M |
|
1067
Outfront Media
OUT
$5.5B
| $18.8M | 0.01% |
1,149,048
-487,032
| -30% | -$8.22M |
|
1068
AutoNation
AN
$6.92B
| $18.7M | 0.01% |
209,967
-29,016
| -12% | -$3.21M |
|
1069
Asbury Automotive
ABG
$3.85B
| $18.7M | 0.01% |
104,469
+31,358
| +43% | +$5.24M |
|
|
SEM
1070
DELISTED
Select Medical
SEM
| $18.7M | 0.01% |
1,398,249
+195,836
| +16% | +$2.53M |
|
1071
National Grid
NGG
$81.3B
| $18.7M | 0.01% |
328,973
-48,435
| -13% | -$2.59M |
|
1072
The Ensign Group
ENSG
$10.7B
| $18.7M | 0.01% |
197,637
-11,874
| -6% | -$1.08M |
|
1073
Evolent Health
EVH
$447M
| $18.7M | 0.01% |
664,976
-471,809
| -42% | -$13.5M |
|
|
APLS
1074
DELISTED
Apellis Pharmaceuticals
APLS
| $18.7M | 0.01% |
360,735
-49,666
| -12% | -$2.63M |
|
|
VBTX
1075
DELISTED
Veritex Holdings
VBTX
| $18.5M | 0.01% |
658,637
+196,182
| +42% | +$5.83M |
|
Similar funds
VFT
Nuveen's Q4 2022 Portfolio in Review
As of Q4 2022, Nuveen held 3,329 positions worth $258B, up 4.5% from $247B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Nuveen withdrew a net $8.74B in Q4 2022, closing 159 positions and reducing 1,986 holdings. Its most notable exit was Twitter, Inc., an estimated $237M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Nuveen opened a new position in Atlassian worth $226M.
- Nuveen's largest Q4 2022 buy was Atlassian: 1,759,716 shares worth $226M.
- Nuveen added most to Prologis in Q4 2022, an estimated $352M increase.
- Nuveen's biggest Q4 2022 reduction was Alnylam Pharmaceuticals, cutting an estimated $3.41B.
- Nuveen fully exited Twitter, Inc. in Q4 2022, selling an estimated $237M.
- Nuveen's ten largest holdings make up 19% of its $258B portfolio in Q4 2022.
- Nuveen opened 40 new positions and closed 159 in Q4 2022.
- Nuveen's portfolio value rose 4.5% quarter-over-quarter to $258B.
Based on Nuveen's 13F filing for Q4 2022, filed 14 Feb 2023.